Condition: Type II Diabetes Mellitus · Sponsor: Sun Pharmaceutical Industries Limited
This is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mellitus subjects who are obese or overweight with weight-related comorbidities. Subjects will be put on either one of the four treatment arms (GL0034, once a week, subcutaneous injection) or placebo arm (once a week, subcutaneous injection) following initial dose-up titration that takes up to approximately 20 weeks. The primary end point is change in HbA1c levels from baseline (Week 0) to Week 36 following treatments in all participants.
This description comes directly from the study's public registry record.
Head, Regulatory Affairs · 9122 66455645 · Clinical.Trial@sunpharma.com
Always discuss trial participation with your own doctor first.
| Lynn Institute of the Ozarks | Little Rock, Arkansas, United States | Recruiting |
| Family First Medical Research Center | Hialeah Gardens, Florida, United States | Recruiting |
| Alliance for Multispecialty Research (AMR Clinical) - Wichita East | Lakeland, Florida, United States | Recruiting |
| CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis) | Lakeland, Florida, United States | Recruiting |
| GTL Medical & Research Group | Miami, Florida, United States | Recruiting |
| Florida Institute for Clinical Research LLC | Orlando, Florida, United States | Recruiting |
| AMR Clinical, El Dorado | El Dorado, Kansas, United States | Recruiting |
| AMR Clinical - Newton | Newton, Kansas, United States | Recruiting |
| Lynn Health Science Institute - Oklahoma City | Oklahoma City, Oklahoma, United States | Recruiting |
| Endolife Specialty Hospitals Pvt. Ltd. | Guntur, Andhra Pradesh, India | Recruiting |
| Life Care Hospital and Research Centre | Bangalore, Karnataka, India | Recruiting |
| Government Medical College | Kozhikode, Kerala, India | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07282743